Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Margolis

Showing results (31-40 of 219) with videos related to

Pageof 22
Sort By:
DNA and Cell Biology|November 22, 2002
The regulation of HIV-1 gene expression: the emerging role of chromatinGuocheng He, Loyda Ylisastigui, David M Margolis
Journal of Virus Eradication|September 16, 2022
Bispecific antibody-derived molecules to target persistent HIV infectionJeffrey L Nordstrom, Guido Ferrari, David M Margolis
Trends in Microbiology|October 5, 2014
Framing expectations in early HIV cure researchKarine Dubé, Gail E Henderson, David M Margolis
Virus Research|December 5, 2016
Detection of human immunodeficiency virus RNAs in living cells using Spinach RNA aptamersBrandon D Burch, Carolina Garrido, David M Margolis
Immunological Reviews|January 31, 2017
HIV antibodies for treatment of HIV infectionDavid M Margolis, Richard A Koup, Guido Ferrari
Expert Reviews in Molecular Medicine|February 12, 2009
Pharmaceutical approaches to eradication of persistent HIV infectionMary-Catherine Bowman, Nancie M Archin, David M Margolis
Pharmacotherapy|December 9, 2004
Atazanavir for the treatment of human immunodeficiency virus infectionAnthony J Busti, Ronald G Hall, David M Margolis
Viruses|August 26, 2023
New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency PreventionCatherine A Lewis, David M Margolis, Edward P Browne
The Journal of Infectious Diseases|April 19, 2008
Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cellsShailesh K Choudhary, Nancy M Archin, David M Margolis
Plos Pathogens|September 3, 2025
HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cellsCatherine A Lewis, David M Margolis, Edward P Browne
Pageof 22

Showing results (31-40 of 219) with videos related to

Sort By:
Pageof 22
DNA and Cell Biology|November 22, 2002
The regulation of HIV-1 gene expression: the emerging role of chromatinGuocheng He, Loyda Ylisastigui, David M Margolis
Journal of Virus Eradication|September 16, 2022
Bispecific antibody-derived molecules to target persistent HIV infectionJeffrey L Nordstrom, Guido Ferrari, David M Margolis
Trends in Microbiology|October 5, 2014
Framing expectations in early HIV cure researchKarine Dubé, Gail E Henderson, David M Margolis
Virus Research|December 5, 2016
Detection of human immunodeficiency virus RNAs in living cells using Spinach RNA aptamersBrandon D Burch, Carolina Garrido, David M Margolis
Immunological Reviews|January 31, 2017
HIV antibodies for treatment of HIV infectionDavid M Margolis, Richard A Koup, Guido Ferrari
Expert Reviews in Molecular Medicine|February 12, 2009
Pharmaceutical approaches to eradication of persistent HIV infectionMary-Catherine Bowman, Nancie M Archin, David M Margolis
Pharmacotherapy|December 9, 2004
Atazanavir for the treatment of human immunodeficiency virus infectionAnthony J Busti, Ronald G Hall, David M Margolis
Viruses|August 26, 2023
New Concepts in Therapeutic Manipulation of HIV-1 Transcription and Latency: Latency Reversal versus Latency PreventionCatherine A Lewis, David M Margolis, Edward P Browne
The Journal of Infectious Diseases|April 19, 2008
Hexamethylbisacetamide and disruption of human immunodeficiency virus type 1 latency in CD4(+) T cellsShailesh K Choudhary, Nancy M Archin, David M Margolis
Plos Pathogens|September 3, 2025
HIV-1 accessory protein Vpr possesses a cryptic p300-dependent transcription-promoting activity that is blocked by histone deacetylases in CD4+ T cellsCatherine A Lewis, David M Margolis, Edward P Browne
Pageof 22